STOCK TITAN

General Motors 144 Filing: 907,024 Shares Planned Sale on 08/28/2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice from General Motors Company (GM) reports a proposed sale of 907,024 shares of Common stock through Morgan Stanley Smith Barney LLC on 08/28/2025 with an aggregate market value of $53,287,660 and the NYSE listed as the exchange. The filing lists the acquisition details by lot: 607,024 shares from an exercise of stock options dated 08/28/2025 paid in cash, 236,466 shares from performance stock units dated 02/13/2017, 60,250 shares from restricted stock units dated 07/18/2011, and 3,284 shares from equity incentive compensation dated 07/18/2011. The filer certifies no undisclosed material adverse information and indicates no securities sold in the past three months.

Positive

  • Full lot-level disclosure showing acquisition date, nature, and payment method for each tranche of shares
  • Filer affirms no undisclosed material adverse information and includes standard Rule 144/10b5-1 references
  • No reported sales of the issuer's securities by the filer in the prior three months

Negative

  • Large proposed insider sale of 907,024 shares with an aggregate market value of $53,287,660, which may be viewed negatively by some investors
  • Majority of shares (607,024) are from a same-day option exercise, indicating immediate post-exercise sale intent

Insights

TL;DR: Large insider sale notice: 907,024 shares (~$53.3M) planned for 08/28/2025; mixture of newly exercised and previously granted equity.

The filing documents a sizable Rule 144 notification for planned disposition on 08/28/2025 through Morgan Stanley. The lot-level detail shows 607,024 shares arising from a same-day option exercise paid in cash, while the balance comprises older equity awards from 2011 and 2017. No sales were reported in the prior three months, and the signer affirms no undisclosed material adverse information. For investors, the notice is a clear disclosure of an impending insider sale but contains no forward-looking statements or company operational details.

TL;DR: Procedural compliance with Rule 144; detailed acquisition provenance provided for the shares to be sold.

The Form 144 supplies the required provenance and payment method for each lot, including a cash-paid option exercise dated the same day as the planned sale for a majority of the shares. Signature attestations regarding material information and 10b5-1 considerations are included in the remarks section. The notice adheres to disclosure norms but does not provide context on any trading plan adoption date or other governance controls beyond the standard representation.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for GM (GM) report?

The form reports a proposed sale of 907,024 common shares on 08/28/2025 through Morgan Stanley with an aggregate market value of $53,287,660 on the NYSE.

What types of equity are being sold according to the filing?

The shares originate from four categories: an exercise of stock options (607,024 shares), performance stock units (236,466), restricted stock units (60,250), and equity incentive compensation (3,284).

Was payment made for the acquired securities and how?

For the stock option lot dated 08/28/2025, the filing lists cash as the payment method; other lots from 2011 and 2017 are listed as non-cash award types or N/A for payment.

Has the filer sold any GM securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the filing state any material undisclosed information about GM?

By signing, the person represents they do not know any material adverse information